Verve Therapeutics
VERV54
$4.61arrow_drop_up5.37%$0.23
VERV54
$4.61
arrow_drop_up5.37%| Key Stats | |
|---|---|
| Open | $4.37 |
| Prev. Close | $4.37 |
| EPS | -2.35 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $370.83M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 4.32 | 4.66 |
| 52 Week Range | 2.96 | 20.12 |
| Ratios | |
|---|---|
| EPS | -2.35 |
| Fundamentals | |
|---|---|
| Payout Ratio | - |
| Industry average yield | 2.89% |
| Last Dividend pay date | - |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
VERV-
US Healthcare Sector-
US Market-
check_circle
VERV / Market
VERV exceeded the US Market which returned -0.39% over the last twenty four hours.check_circle
VERV / Healthcare Sector
VERV exceeded the US Healthcare sector which returned 3.30% over the last twenty four hours.Verve Therapeutics (VERV) Statistics
Keep an eye on Verve Therapeutics
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How has Verve Therapeutics (VERV) stock's performance compared to its sector and the market over the past year?
Over the past year, Verve Therapeutics (VERV) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 16.71%, Verve Therapeutics has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 26.19%, it has fallen short of the market average. This comparison highlights Verve Therapeutics's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Verve Therapeutics (VERV) stock?
The PE ratio for Verve Therapeutics (VERV) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help
What is the EPS of Verve Therapeutics (VERV) stock?
The Earnings Per Share (EPS) for Verve Therapeutics (VERV), calculated on a diluted basis, is -$2.35. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Verve Therapeutics (VERV) stock?
The operating margin for Verve Therapeutics (VERV) is -428.65%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Verve Therapeutics (VERV) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Verve Therapeutics (VERV) is -$221.91M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Verve Therapeutics (VERV) have?
Verve Therapeutics (VERV) has a total debt of $69.98M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$102.58M.